Cargando…

RANKL neutralisation prevents osteoclast activation in a human in vitro ameloblastoma-bone model

Ameloblastoma is a benign, locally invasive epithelial odontogenic neoplasm of the jaw. Treatment of choice is jaw resection, often resulting in significant morbidity. The aim of this study was to recapitulate ameloblastoma in a completely humanised 3D disease model containing ameloblastoma cells, o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pape, Judith, Bakkalci, Deniz, Hosni, Rawiya Al, Simpson, Benjamin S, Heikinheimo, Kristiina, Fedele, Stefano, Cheema, Umber
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793035/ https://www.ncbi.nlm.nih.gov/pubmed/36582941 http://dx.doi.org/10.1177/20417314221140500

Ejemplares similares

Modelling stromal compartments to recapitulate the ameloblastoma tumour microenvironment
por: Bakkalci, Deniz, et al.
Publicado: (2022)

Associated changes in stiffness of collagen scaffolds during osteoblast mineralisation and bone formation
por: Bakkalci, Deniz, et al.
Publicado: (2022)

Bioengineering the ameloblastoma tumour to study its effect on bone nodule formation
por: Bakkalci, Deniz, et al.
Publicado: (2021)

Reprogramming bone progenitor identity and potency through control of collagen density and oxygen tension
por: Al Hosni, Rawiya, et al.
Publicado: (2022)

Biophysical Parameters Can Induce Epithelial-to-Mesenchymal Phenotypic and Genotypic Changes in HT-29 Cells: A Preliminary Study
por: Pape, Judith, et al.
Publicado: (2023)

Tissue-Engineering the Fibrous Pancreatic Tumour Stroma Capsule in 3D Tumouroids to Demonstrate Paclitaxel Response
por: Pape, Judith, et al.
Publicado: (2021)

The regulation of bone turnover in ameloblastoma using an organotypic in vitro co-culture model
por: Eriksson, Tuula M, et al.
Publicado: (2016)

Comparative transcriptional profiling of canine acanthomatous ameloblastoma and homology with human ameloblastoma
por: Peralta, Santiago, et al.
Publicado: (2021)

RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro
por: Sutherland, Karen A, et al.
Publicado: (2009)

Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
por: Hu, Zi’ang, et al.
Publicado: (2018)

Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption
por: Jang, Jin Sun, et al.
Publicado: (2019)

Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption
por: McDonald, Michelle M., et al.
Publicado: (2021)

Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption
por: McDonald, Michelle M., et al.
Publicado: (2021)

ELMO1 Regulates RANKL-Stimulated Differentiation and Bone Resorption of Osteoclasts
por: Liang, Xinyue, et al.
Publicado: (2021)

High frequency of BRAF V600E mutations in ameloblastoma
por: Kurppa, Kari J, et al.
Publicado: (2014)

Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
por: Lim, Soomin, et al.
Publicado: (2023)

Osteoclast regulation of osteoblasts via RANK-RANKL reverse signal transduction in vitro
por: Zhang, Shiqian, et al.
Publicado: (2017)

Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride
por: Chen, Zhang, et al.
Publicado: (2022)

Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss
por: Xiong, Jinhu, et al.
Publicado: (2018)

RO4929097 regulates RANKL-induced osteoclast formation and LPS-mediated bone resorption
por: Huang, Tao, et al.
Publicado: (2021)

Effect of amorphous silica nanoparticles on in vitro RANKL-induced osteoclast differentiation in murine macrophages
por: Nabeshi, Hiromi, et al.
Publicado: (2011)

Signaling crosstalk between RANKL and interferons in osteoclast differentiation
por: Takayanagi, Hiroshi, et al.
Publicado: (2002)

3D Cancer Models: The Need for a Complex Stroma, Compartmentalization and Stiffness
por: Pape, Judith, et al.
Publicado: (2021)

Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone
por: Xiong, Jinhu, et al.
Publicado: (2015)

Water extract of Uncaria sinensis suppresses RANKL-induced bone loss by attenuating osteoclast differentiation and bone resorption
por: Ha, Hyunil, et al.
Publicado: (2017)

Clathrin-dependent endocytosis of membrane-bound RANKL in differentiated osteoclasts
por: Narducci, P., et al.
Publicado: (2010)

Serum amyloid A inhibits RANKL-induced osteoclast formation
por: Oh, Eunseo, et al.
Publicado: (2015)

Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression
por: Hwang, Youn-Hwan, et al.
Publicado: (2018)

The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation
por: Qu, Hongyi, et al.
Publicado: (2021)

Eurycoma longifolia, a promising suppressor of RANKL-induced differentiation and activation of osteoclasts: An in vitro mechanistic evaluation
por: Thu, Hnin Ei, et al.
Publicado: (2019)

Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro
por: Wang, Chuandong, et al.
Publicado: (2017)

Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo
por: Li, Yu-Xi, et al.
Publicado: (2020)

Carboxypeptidase E Is a Novel Modulator of RANKL-Induced Osteoclast Differentiation
por: Kim, Hyun-Ju, et al.
Publicado: (2014)

Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation
por: Lee, Kyunghee, et al.
Publicado: (2016)

MicroRNA-26a Regulates RANKL-Induced Osteoclast Formation
por: Kim, Kabsun, et al.
Publicado: (2015)

Spi-C positively regulates RANKL-mediated osteoclast differentiation and function
por: Go, Eun Mi, et al.
Publicado: (2020)

Retinoic Acid Increases Proliferation of Human Osteoclast Progenitors and Inhibits RANKL-Stimulated Osteoclast Differentiation by Suppressing RANK
por: Hu, Lijuan, et al.
Publicado: (2010)

Fangchinoline protects against bone loss in OVX mice via inhibiting osteoclast formation, bone resorption and RANKL-induced signaling
por: Zhou, Lin, et al.
Publicado: (2020)

Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis
por: Ohshiba, T, et al.
Publicado: (2003)

RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis
por: Yue, Zhiying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ba19arehcdr1k0fvcgmladhjc3